P. De Feudis

552 total citations
8 papers, 245 citations indexed

About

P. De Feudis is a scholar working on Oncology, Cancer Research and Biotechnology. According to data from OpenAlex, P. De Feudis has authored 8 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Cancer Research and 3 papers in Biotechnology. Recurrent topics in P. De Feudis's work include Cancer-related Molecular Pathways (4 papers), Cancer Research and Treatments (3 papers) and Cancer, Lipids, and Metabolism (2 papers). P. De Feudis is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Cancer Research and Treatments (3 papers) and Cancer, Lipids, and Metabolism (2 papers). P. De Feudis collaborates with scholars based in Italy and Spain. P. De Feudis's co-authors include Maurizio D’Incalci, Massimo Broggini, Patrizia Russo, Domizia Debernardis, Silvio Parodi, Monica Valenti, Faina Vikhanskaya, Dario Arzani, Patrizia Beccaglia and Eugenio Erba and has published in prestigious journals such as British Journal of Cancer, Neoplasia and European Journal of Cancer Supplements.

In The Last Decade

P. De Feudis

8 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. De Feudis Italy	6	156	140	45	43	38	8	245
Monica Valenti Italy	8	227 1.5×	238 1.7×	56 1.2×	38 0.9×	35 0.9×	17	348
Esther M. Hoogervorst Netherlands	10	195 1.3×	282 2.0×	103 2.3×	53 1.2×	51 1.3×	12	367
Yasunari Ogiso Japan	7	171 1.1×	319 2.3×	38 0.8×	85 2.0×	23 0.6×	7	393
Gourish Mondal United States	11	110 0.7×	304 2.2×	79 1.8×	85 2.0×	8 0.2×	15	459
Jude Alsarraj United States	6	141 0.9×	356 2.5×	115 2.6×	26 0.6×	18 0.5×	6	469
Thippeswamy Gulappa United States	10	72 0.5×	211 1.5×	49 1.1×	16 0.4×	4 0.1×	14	324
Purificación Estévez-García Spain	8	78 0.5×	183 1.3×	121 2.7×	51 1.2×	5 0.1×	19	272
Rachel Amado Bortnick United States	3	194 1.2×	332 2.4×	71 1.6×	28 0.7×	43 1.1×	3	401
Jianhua Xu China	8	86 0.6×	180 1.3×	107 2.4×	18 0.4×	5 0.1×	13	302
Wan Chang China	11	125 0.8×	319 2.3×	97 2.2×	32 0.7×	5 0.1×	11	380

Countries citing papers authored by P. De Feudis

Since Specialization

Citations

This map shows the geographic impact of P. De Feudis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. De Feudis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. De Feudis more than expected).

Fields of papers citing papers by P. De Feudis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. De Feudis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. De Feudis. The network helps show where P. De Feudis may publish in the future.

Co-authorship network of co-authors of P. De Feudis

This figure shows the co-authorship network connecting the top 25 collaborators of P. De Feudis. A scholar is included among the top collaborators of P. De Feudis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. De Feudis. P. De Feudis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Giovine, Stefano Di, P. De Feudis, Gennaro Colella, et al.. (2006). 633 POSTER Effect of estrogen on cathepsin B activity and antitumor efficacy of Paclitaxel Poliglumex in human tumor xenografts. European Journal of Cancer Supplements. 4(12). 191–191. 2 indexed citations

Bergottini, Raffaella, Enrico Radaelli, Stefano Di Giovine, et al.. (2006). 637 POSTER Paclitaxel poliglumex cellular uptake by normal tissues and human tumor xenograft: an IHC study in nude mice. European Journal of Cancer Supplements. 4(12). 192–192. 2 indexed citations

Feudis, P. De, Sara Vignati, Cosmo Rossi, et al.. (2000). Driving p53 Response to Bax Activation Greatly Enhances Sensitivity to Taxol by Inducing Massive Apoptosis. Neoplasia. 2(3). 202–207. 22 indexed citations

Bergamaschi, Daniele, Simona Ronzoni, Stefano Taverna, et al.. (1998). Cell cycle perturbations and apoptosis induced by isohomohalichondrin B (IHB), a natural marine compound. British Journal of Cancer. 79(2). 267–277. 12 indexed citations

Desiderio, M. A., et al.. (1997). Treatment with inhibitors of polyamine biosynthesis, which selectively lower intracellular spermine, does not affect the activity of alkylating agents but antagonizes the cytotoxicity of DNA topoisomerase II inhibitors. British Journal of Cancer. 75(7). 1028–1034. 14 indexed citations

Feudis, P. De, Domizia Debernardis, Patrizia Beccaglia, et al.. (1997). DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status. British Journal of Cancer. 76(4). 474–479. 56 indexed citations

Debernardis, Domizia, P. De Feudis, Faina Vikhanskaya, et al.. (1997). p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.. PubMed. 57(5). 870–4. 125 indexed citations

Debernardis, Domizia, P. De Feudis, Faina Vikhanskaya, et al.. (1997). p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res.. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact